124 related articles for article (PubMed ID: 25139631)
1. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
[TBL] [Abstract][Full Text] [Related]
2. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
3. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
Desai NR; Shrank WH; Fischer MA; Avorn J; Liberman JN; Schneeweiss S; Pakes J; Brennan TA; Choudhry NK
Am J Med; 2012 Mar; 125(3):302.e1-7. PubMed ID: 22340932
[TBL] [Abstract][Full Text] [Related]
4. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
[TBL] [Abstract][Full Text] [Related]
5. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.
Mahmoud F; Mueller T; Mullen A; Sainsbury C; Rushworth GF; Kurdi A
Diabetes Obes Metab; 2024 Jul; 26(7):2684-2694. PubMed ID: 38558305
[TBL] [Abstract][Full Text] [Related]
6. The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015.
Wang X; Cao Y; Wu Y; Yang C; Song J; Tian Y; Wang M; Li M; Wu Y; Hu Y
Medicine (Baltimore); 2019 Feb; 98(8):e14370. PubMed ID: 30813137
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.
Yu O; Azoulay L; Yin H; Filion KB; Suissa S
Am J Med; 2018 Mar; 131(3):317.e11-317.e22. PubMed ID: 29032229
[TBL] [Abstract][Full Text] [Related]
8. Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study.
van Dalem J; Brouwers MCGJ; Burden AM; Stehouwer CDA; Klungel OH; de Vries F; Driessen JHM
Diabetes Res Clin Pract; 2021 Jun; 176():108828. PubMed ID: 33894280
[TBL] [Abstract][Full Text] [Related]
9. [Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data].
Lappe V; Köster I; Schubert I
Dtsch Med Wochenschr; 2017 Jan; 142(1):e1-e9. PubMed ID: 28056470
[TBL] [Abstract][Full Text] [Related]
10. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
[TBL] [Abstract][Full Text] [Related]
11. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
[TBL] [Abstract][Full Text] [Related]
12. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
Zghebi SS; Steinke DT; Rutter MK; Emsley RA; Ashcroft DM
Diabetes Obes Metab; 2016 Sep; 18(9):916-24. PubMed ID: 27177784
[TBL] [Abstract][Full Text] [Related]
13. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
[TBL] [Abstract][Full Text] [Related]
14. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R; Gruenberger JB; Bader G; Dworak M
Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
[TBL] [Abstract][Full Text] [Related]
15. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study.
Raebel MA; Xu S; Goodrich GK; Schroeder EB; Schmittdiel JA; Segal JB; O'Connor PJ; Nichols GA; Lawrence JM; Kirchner HL; Elston Lafata J; Butler M; Newton KM; Steiner JF
Ann Pharmacother; 2013 Oct; 47(10):1280-91. PubMed ID: 24259692
[TBL] [Abstract][Full Text] [Related]
16. The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.
Lub R; Denig P; van den Berg PB; Hoogenberg K; de Jong-van den Berg LT
Br J Clin Pharmacol; 2006 Dec; 62(6):660-5. PubMed ID: 16796700
[TBL] [Abstract][Full Text] [Related]
17. Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy.
Biondi-Zoccai G; Pinto A; Versaci F; Procaccini E; Neri G; Sesti G; Uccioli L; Vetere M; Peruzzi M; Nudi F
J Cardiovasc Pharmacol; 2016 Aug; 68(2):162-70. PubMed ID: 27074768
[TBL] [Abstract][Full Text] [Related]
18. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
19. Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines.
Wang TY; Eguale T; Tamblyn R
BMC Health Serv Res; 2013 Oct; 13():442. PubMed ID: 24160916
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
